229 related articles for article (PubMed ID: 10589053)
1. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Wanapirak C; Sirichotiyakul S
Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
[TBL] [Abstract][Full Text] [Related]
2. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Dec; 34(13):1277-82. PubMed ID: 25046597
[TBL] [Abstract][Full Text] [Related]
3. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Piyamongkol W; Tongprasert F; Srisupundit K; Luewan S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
[TBL] [Abstract][Full Text] [Related]
4. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
[TBL] [Abstract][Full Text] [Related]
5. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
6. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity.
Srisupundit K; Piyamongkol W; Tongsong T
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):694-7. PubMed ID: 19350531
[TBL] [Abstract][Full Text] [Related]
7. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
Srisupundit K; Piyamongkol W; Tongsong T
Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
[TBL] [Abstract][Full Text] [Related]
8. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
[TBL] [Abstract][Full Text] [Related]
9. Fetal liver length measurement at mid-pregnancy among fetuses at risk as a predictor of hemoglobin Bart's disease.
Luewan S; Tongprasert F; Piyamongkol W; Wanapirak C; Tongsong T
J Perinatol; 2011 Mar; 31(3):157-60. PubMed ID: 20651692
[TBL] [Abstract][Full Text] [Related]
10. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks' gestation.
Lam YH; Tang MH
Prenat Diagn; 1997 Jun; 17(6):501-4. PubMed ID: 9203207
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of placental volume measured by virtual organ computer-aided analysis in prediction of fetal hemoglobin Bart's disease in late first trimester.
Bootchaingam P; Charoenratana C; Tongsong T; Luewan S
J Clin Ultrasound; 2021 Jul; 49(6):533-537. PubMed ID: 33860959
[TBL] [Abstract][Full Text] [Related]
13. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation.
Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Prenat Diagn; 2014 Mar; 34(3):230-4. PubMed ID: 24318930
[TBL] [Abstract][Full Text] [Related]
14. Prenatal eradication of Hb Bart's hydrops fetalis.
Tongsong T; Wanapirak C; Sirivatanapa P; Sa-nguansermsri T; Sirichotiyakul S; Piyamongkol W; Chanprapaph P; Steger HF; Sekararithi R; Tuggapichitti A
J Reprod Med; 2001 Jan; 46(1):18-22. PubMed ID: 11209626
[TBL] [Abstract][Full Text] [Related]
15. Prevention and control of Hb Bart's disease in Guangxi Zhuang Autonomous Region, China.
He S; Zhang Q; Li D; Chen S; Tang Y; Chen Q; Zheng C
Eur J Obstet Gynecol Reprod Biol; 2014 Jul; 178():138-41. PubMed ID: 24792538
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
Lam YH; Tang MH
Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
[TBL] [Abstract][Full Text] [Related]
17. Fetal myocardial performance (Tei) index in fetal hemoglobin Bart's disease.
Luewan S; Tongprasert F; Srisupundit K; Tongsong T
Ultraschall Med; 2013 Aug; 34(4):355-8. PubMed ID: 23386484
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of homozygous alpha-thalassemia-1 by cell-free fetal DNA in maternal plasma.
Sirichotiyakul S; Charoenkwan P; Sanguansermsri T
Prenat Diagn; 2012 Jan; 32(1):45-9. PubMed ID: 22031039
[TBL] [Abstract][Full Text] [Related]
19. Splenic circumference at midpregnancy as a predictor of hemoglobin Bart's disease among fetuses at risk.
Srisupundit K; Tongprasert F; Luewan S; Sirichotiyakul S; Tongsong T
Gynecol Obstet Invest; 2011; 72(1):63-7. PubMed ID: 21389673
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive prenatal detection of haemoglobin Bart's disease by cardiothoracic ratio during the first trimester.
Zhen L; Pan M; Han J; Yang X; Ou YM; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():92-5. PubMed ID: 26262767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
